The significance of addind rheumatological assessment to the multidisciplinary team in the diagnosis of interstitial lung disease.

G. Epstein Shochet (Kfar-Saba, Israel)

Source: International Congress 2017 – Best clinical practice for the management of chronic lung diseases
Session: Best clinical practice for the management of chronic lung diseases
Session type: Poster Discussion
Number: 363
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Epstein Shochet (Kfar-Saba, Israel). The significance of addind rheumatological assessment to the multidisciplinary team in the diagnosis of interstitial lung disease.. 363

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Demonstration of diagnostic and prognostic benefits of an interstitial lung disease (ILD) multidisciplinary team meeting
Source: Annual Congress 2011 - Clinical approach of diffuse parenchymal lung disease
Year: 2011


A contemporary practical approach to the multidisciplinary management of unclassifiable interstitial lung disease
Source: Eur Respir J, 58 (6) 2100276; 10.1183/13993003.00276-2021
Year: 2021



Clinical management implications of histologic information provided by lung biopsy in the multidisciplinary evaluation of interstitial lung diseases.
Source: Virtual Congress 2020 – The hot and cold of interventional pulmonology
Year: 2020




Multidisciplinary diagnosis of interstitial lung disease: a retrospective analysis
Source: International Congress 2019 – Medical education
Year: 2019

The characterisation of interstitial lung disease multidisciplinary team meetings: a global study
Source: ERJ Open Res, 5 (2) 00209-2018; 10.1183/23120541.00209-2018
Year: 2019



The role of the radiologist in the multidisciplinary diagnosis of idiopathic pulmonary fibrosis
Source: Virtual Congress 2020 – The role of the radiologist in the multidisciplinary diagnosis of idiopathic pulmonary fibrosis
Year: 2020

The multidisciplinary approach in the diagnosis of idiopathic pulmonary fibrosis: a patient case-based review
Source: Eur Respir Rev 2015; 24: 69-77
Year: 2015



An international survey on genetics in clinical practice for interstitial lung disease.
Source: Virtual Congress 2021 – Exercise tolerance, supportive care and more in non-pulmonary fibrosis interstitial lung diseases
Year: 2021


The value of a specialist nurse-lead interstitial lung disease clinic, patients’ views
Source: International Congress 2015 – Kaleidoscope of nursing research
Year: 2015


Impact of a specialist respiratory pharmacist in the management of interstitial lung disease
Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside
Year: 2018

Transbronchial biopsy adequacy and sample size in a multidisciplinary team approach to interstitial lung disease diagnosis: one-year Padova experience
Source: International Congress 2017 – ILDs: clinical problems
Year: 2017


Diffuse lung disease in infancy: a working classification of the pediatric interstitial lung disease (pILD) multidisciplinary cooperative group
Source: Eur Respir J 2005; 26: Suppl. 49, 500s
Year: 2005

Recent advances in the pathogenesis and clinical evaluation of pulmonary fibrosis
Source: Eur Respir Rev 2012; 21: 48-56
Year: 2012



Global characterisation of routine care interstitial lung disease diagnostic practice
Source: International Congress 2017 – IPF: from the bench to the bedside
Year: 2017


Exercise testing in interstitial lung disease diagnosis and management
Source: Eur Respir Mon; 2009: 46: 7
Year: 2009

Multidisciplinary team meetings dedicated to children interstitial lung diseases (chILD) – a 2-years experience
Source: Virtual Congress 2020 – Tip the hat to paediatric bronchology
Year: 2020




Role of lung biopsies in the diagnosis of interstitial lung diseases in a clinical real-life setting
Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases
Year: 2021


The future of treatment for interstitial lung diseases: the patient’s and physician’s perspective
Source: International Congress 2019 – Rare lung diseases
Year: 2019


Supportive care of patients with fibrosing interstitial lung disease: answering a great clinical need
Source: Breathe, 16 (3) 200066; 10.1183/20734735.0066-2020
Year: 2020



The Dutch multidisciplinary experience
Source: Annual Congress 2007 - Primary care: delivering quality respiratory care in primary care: a multidisciplinary international perspective
Year: 2007